Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Amos

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Journal of Oral Pathology|February 1, 1987
Absence of circulating IgG immune complexes in minor recurrent aphthous ulcerationJ Bagg, B D Williams, N Amos, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1992
Accumulation of polyvinylpyrrolidone within the inflamed paws of adjuvant-induced arthritic ratsL Seale, W G Love, N Amos, et al.
British Journal of Pharmacology|September 28, 1999
Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritisA S Williams, S G Jones, R M Goodfellow, et al.
Clinical and Experimental Immunology|April 1, 1977
Guinea-pig nephrotoxic nephritis II. Autologous phase: complement activation without detectable injuryI J Simpson, N M Thomson, N Amos, et al.
British Journal of Rheumatology|March 1, 1995
The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytesA S Williams, Y L Punn, N Amos, et al.
Clinical and Experimental Immunology|March 1, 1975
Guinea-pig nephrotoxic nephritis. I. The role of complement and polymorphonuclear leucocytes and the effect of antibody subclass and fragments in the heterologous phaseI J Simpson, N Amos, D J Evans, et al.
Kidney International|October 1, 1984
The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritisA J Rees, D K Peters, N Amos, et al.
Clinical and Experimental Immunology|May 1, 1991
Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditionsD A Oleesky, R H Daniels, B D Williams, et al.
Clinical and Experimental Immunology|June 1, 1976
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitroN Amos, J G Sissons, J F Girard, et al.
Clinical and Experimental Immunology|February 1, 1983
Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar ratesJ A Schifferli, N Amos, C D Pusey, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Journal of Oral Pathology|February 1, 1987
Absence of circulating IgG immune complexes in minor recurrent aphthous ulcerationJ Bagg, B D Williams, N Amos, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1992
Accumulation of polyvinylpyrrolidone within the inflamed paws of adjuvant-induced arthritic ratsL Seale, W G Love, N Amos, et al.
British Journal of Pharmacology|September 28, 1999
Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritisA S Williams, S G Jones, R M Goodfellow, et al.
Clinical and Experimental Immunology|April 1, 1977
Guinea-pig nephrotoxic nephritis II. Autologous phase: complement activation without detectable injuryI J Simpson, N M Thomson, N Amos, et al.
British Journal of Rheumatology|March 1, 1995
The effect of liposomally conjugated methotrexate upon mediator release from human peripheral blood monocytesA S Williams, Y L Punn, N Amos, et al.
Clinical and Experimental Immunology|March 1, 1975
Guinea-pig nephrotoxic nephritis. I. The role of complement and polymorphonuclear leucocytes and the effect of antibody subclass and fragments in the heterologous phaseI J Simpson, N Amos, D J Evans, et al.
Kidney International|October 1, 1984
The influence of HLA-linked genes on the severity of anti-GBM antibody-mediated nephritisA J Rees, D K Peters, N Amos, et al.
Clinical and Experimental Immunology|May 1, 1991
Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditionsD A Oleesky, R H Daniels, B D Williams, et al.
Clinical and Experimental Immunology|June 1, 1976
The cofactors required by C3 nephritic factor to generate a C3 convertase in vitroN Amos, J G Sissons, J F Girard, et al.
Clinical and Experimental Immunology|February 1, 1983
Metabolism of IgG in type II mixed essential cryoglobulinaemia--autologous cryoprecipitated and normal homologous IgG are incorporated into complexes and metabolized in vivo at similar ratesJ A Schifferli, N Amos, C D Pusey, et al.
Pageof 7